Program:
The value of currently available antiretroviral drugs has been severely limited by the extraordinary mutability of HIV, which has also proven to be very adept at evading the induction of protective immunity via immunization. The development of effective therapies against HIV, therefore, is going to be dependent on novel strategies, including approaches based on models of pathogenesis, infection and replication that run counter to common beliefs. The selection of new targets that inherently limit the potential for drug resistance to develop, or new gene therapy or immunological approaches, may prove to be critical.
Registration :
Cambridge Healthtech Institute
1037 Chestnut Street
Newton Upper Falls, MA 02164 USA
tel: 617-630-1300
fax: 617-630-1325
Deadline for Abstracts: 12/95
Email for Requests and Registration: chi@healthtech.com